The functional genomic studies of curcumin

Seminars in Cancer Biology

Volumn 46, Issue , 2017, Pages 107-118

  Huminiecki, Lukasz ^a   Horbańczuk, Jarosław ^a   Atanasov, Atanas G ^a,b  

^a INSTITUTE OF GENETICS AND ANIMAL BREEDING   (Poland)

^b UNIVERSITY OF VIENNA   (Austria)

Author keywords

Cancer; Cell cycle; Curcumin; Functional genomics; Microarrays

Indexed keywords

COMPLEMENTARY DNA; CURCUMIN; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MICRORNA; MICRORNA 124 3P; MICRORNA 132 3P; MICRORNA 183 5P; MICRORNA 192 5P; MICRORNA 194 5P; MICRORNA 215; MICRORNA 223 3P; MICRORNA 602; MITOMYCIN; UNCLASSIFIED DRUG;

ANTINEOPLASTIC ACTIVITY; APOPTOSIS; BIOINFORMATICS; DNA METHYLATION; DOWN REGULATION; FUNCTIONAL GENOMICS; GENE EXPRESSION PROFILING; HUMAN; IN VITRO STUDY; IN VIVO STUDY; INCUBATION TIME; MICROARRAY ANALYSIS; NEXT GENERATION SEQUENCING; NONHUMAN; PLEIOTROPY; REPRODUCIBILITY; REVIEW; RNA SEQUENCE; SIGNAL TRANSDUCTION; UPREGULATION; CELL PROLIFERATION; DIET THERAPY; DRUG EFFECT; GENE EXPRESSION REGULATION; GENETICS; GENOMICS; HUMAN GENOME; NEOPLASM; PATHOLOGY;

APOPTOSIS; CELL PROLIFERATION; CURCUMIN; GENE EXPRESSION REGULATION, NEOPLASTIC; GENOME, HUMAN; GENOMICS; HUMANS; NEOPLASMS;

EID: 85017411163     PISSN: 1044579X     EISSN: 10963650     Source Type: Journal    
DOI: 10.1016/j.semcancer.2017.04.002     Document Type: Review

References (74)

1. Menon, V.P., Sudheer, A.R., Antioxidant and anti-inflammatory properties of curcumin. Adv. Exp. Med. Biol. 595 (2007), 105–125.
2. Wongcharoen, W., Phrommintikul, A., The protective role of curcumin in cardiovascular diseases. Int. J. Cardiol. 133:2 (2009), 145–151.
3. Wongcharoen, W., Jai-Aue, S., Phrommintikul, A., Nawarawong, W., Woragidpoonpol, S., Tepsuwan, T., Sukonthasarn, A., Apaijai, N., Chattipakorn, N., Effects of curcuminoids on frequency of acute myocardial infarction after coronary artery bypass grafting. Am. J. Cardiol. 110:1 (2012), 40–44.
4. Agarwal, R., Goel, S.K., Behari, J.R., Detoxification and antioxidant effects of curcumin in rats experimentally exposed to mercury. J. Appl. Toxicol. 30:5 (2010), 457–468.
5. Chandran, B., Goel, A., A randomized, pilot study to assess the efficacy and safety of curcumin in patients with active rheumatoid arthritis. Phytother. Res. 26:11 (2012), 1719–1725.
6. Ahmed, S., Anuntiyo, J., Malemud, C.J., Haqqi, T.M., Biological basis for the use of botanicals in osteoarthritis and rheumatoid arthritis: a review. Evid. Based Complement. Alternat. Med. 2:3 (2005), 301–308.
7. Ramassamy, C., Emerging role of polyphenolic compounds in the treatment of neurodegenerative diseases: a review of their intracellular targets. Eur. J. Pharmacol. 545:1 (2006), 51–64.
8. Cole, G.M., Teter, B., Frautschy, S.A., Neuroprotective effects of curcumin. Adv. Exp. Med. Biol. 595 (2007), 197–212.
9. Bright, J.J., Curcumin and autoimmune disease. Adv. Exp. Med. Biol. 595 (2007), 425–451.
10. Sharma, R.A., Gescher, A.J., Steward, W.P., Curcumin: the story so far. Eur. J. Cancer 41:13 (2005), 1955–1968.
11. Maheshwari, R.K., Singh, A.K., Gaddipati, J., Srimal, R.C., Multiple biological activities of curcumin: a short review. Life Sci. 78:18 (2006), 2081–2087.
12. Kunnumakkara, A.B., Anand, P., Aggarwal, B.B., Curcumin inhibits proliferation, invasion, angiogenesis and metastasis of different cancers through interaction with multiple cell signaling proteins. Cancer Lett. 269:2 (2008), 199–225.
13. Kasi, P.D., Tamilselvam, R., Skalicka-Wozniak, K., Nabavi, S.F., Daglia, M., Bishayee, A., Pazoki-Toroudi, H., Nabavi, S.M., Molecular targets of curcumin for cancer therapy: an updated review. Tumour Biol. 37:10 (2016), 13017–13028.
14. Aggarwal, B.B., Kumar, A., Bharti, A.C., Anticancer potential of curcumin: preclinical and clinical studies. Anticancer Res. 23:1A (2003), 363–398.
15. Rao, C.V., Simi, B., Reddy, B.S., Inhibition by dietary curcumin of azoxymethane-induced ornithine decarboxylase, tyrosine protein kinase, arachidonic acid metabolism and aberrant crypt foci formation in the rat colon. Carcinogenesis 14:11 (1993), 2219–2225.
16. Rao, C.V., Rivenson, A., Simi, B., Reddy, B.S., Chemoprevention of colon carcinogenesis by dietary curcumin, a naturally occurring plant phenolic compound. Cancer Res. 55:2 (1995), 259–266.
17. Pereira, M.A., Grubbs, C.J., Barnes, L.H., Li, H., Olson, G.R., Eto, I., Juliana, M., Whitaker, L.M., Kelloff, G.J., Steele, V.E., Lubet, R.A., Effects of the phytochemicals, curcumin and quercetin, upon azoxymethane-induced colon cancer and 7,12-dimethylbenz[a]anthracene-induced mammary cancer in rats. Carcinogenesis 17:6 (1996), 1305–1311.
18. Mahmoud, N.N., Carothers, A.M., Grunberger, D., Bilinski, R.T., Churchill, M.R., Martucci, C., Newmark, H.L., Bertagnolli, M.M., Plant phenolics decrease intestinal tumors in an animal model of familial adenomatous polyposis. Carcinogenesis 21:5 (2000), 921–927.
19. Perkins, S., Verschoyle, R.D., Hill, K., Parveen, I., Threadgill, M.D., Sharma, R.A., Williams, M.L., Steward, W.P., Gescher, A.J., Chemopreventive efficacy and pharmacokinetics of curcumin in the min/+ mouse, a model of familial adenomatous polyposis. Cancer Epidemiol. Biomark. Prev. 11:6 (2002), 535–540.
20. Kawamori, T., Lubet, R., Steele, V.E., Kelloff, G.J., Kaskey, R.B., Rao, C.V., Reddy, B.S., Chemopreventive effect of curcumin, a naturally occurring anti-inflammatory agent, during the promotion/progression stages of colon cancer. Cancer Res. 59:3 (1999), 597–601.
21. Huang, M.T., Lou, Y.R., Ma, W., Newmark, H.L., Reuhl, K.R., Conney, A.H., Inhibitory effects of dietary curcumin on forestomach, duodenal, and colon carcinogenesis in mice. Cancer Res. 54:22 (1994), 5841–5847.
22. Collett, G.P., Robson, C.N., Mathers, J.C., Campbell, F.C., Curcumin modifies Apc(min) apoptosis resistance and inhibits 2-amino 1-methyl-6-phenylimidazo[4 5-b]pyridine (PhIP) induced tumour formation in Apc(min) mice. Carcinogenesis 22:5 (2001), 821–825.
23. Shishodia, S., Molecular mechanisms of curcumin action: gene expression. Biofactors 39:1 (2013), 37–55.
24. Sokolosky, M.L., Stadelman, K.M., Chappell, W.H., Abrams, S.L., Martelli, A.M., Stivala, F., Libra, M., Nicoletti, F., Drobot, L.B., Franklin, R.A., Steelman, L.S., McCubrey, J.A., Involvement of Akt-1 and mTOR in sensitivity of breast cancer to targeted therapy. Oncotarget 2:7 (2011), 538–550.
25. McCubrey, J.A., Steelman, L.S., Chappell, W.H., Abrams, S.L., Montalto, G., Cervello, M., Nicoletti, F., Fagone, P., Malaponte, G., Mazzarino, M.C., Candido, S., Libra, M., Basecke, J., Mijatovic, S., Maksimovic-Ivanic, D., Milella, M., Tafuri, A., Cocco, L., Evangelisti, C., Chiarini, F., Martelli, A.M., Mutations and deregulation of Ras/Raf/MEK/ERK and PI3K/PTEN/Akt/mTOR cascades which alter therapy response. Oncotarget 3:9 (2012), 954–987.
26. Zhao, G., Han, X., Zheng, S., Li, Z., Sha, Y., Ni, J., Sun, Z., Qiao, S., Song, Z., Curcumin induces autophagy, inhibits proliferation and invasion by downregulating AKT/mTOR signaling pathway in human melanoma cells. Oncol. Rep. 35:2 (2016), 1065–1074.
27. Zhu, F.Q., Chen, M.J., Zhu, M., Zhao, R.S., Qiu, W., Xu, X., Liu, H., Zhao, H.W., Yu, R.J., Wu, X.F., Zhang, K., Huang, H., Curcumin suppresses epithelial-mesenchymal transition of renal tubular epithelial cells through the inhibition of Akt/mTOR pathway. Biol. Pharm. Bull. 40:1 (2017), 17–24.
28. Yun, J.H., Park, Y.G., Lee, K.M., Kim, J., Nho, C.W., Curcumin induces apoptotic cell death via Oct4 inhibition and GSK-3beta activation in NCCIT cells. Mol. Nutr. Food Res. 59:6 (2015), 1053–1062.
29. Sidhar, H., Giri, R.K., Induction of Bex genes by curcumin is associated with apoptosis and activation of p53 in N2a neuroblastoma cells. Sci. Rep., 7, 2017, 41420.
30. Marin, Y.E., Wall, B.A., Wang, S., Namkoong, J., Martino, J.J., Suh, J., Lee, H.J., Rabson, A.B., Yang, C.S., Chen, S., Ryu, J.H., Curcumin downregulates the constitutive activity of NF-kappaB and induces apoptosis in novel mouse melanoma cells. Melanoma Res. 17:5 (2007), 274–283.
31. Surh, Y.J., Chun, K.S., Cha, H.H., Han, S.S., Keum, Y.S., Park, K.K., Lee, S.S., Molecular mechanisms underlying chemopreventive activities of anti-inflammatory phytochemicals: down-regulation of COX-2 and iNOS through suppression of NF-kappa B activation. Mutat. Res. 480–481 (2001), 243–268.
32. Plummer, S.M., Holloway, K.A., Manson, M.M., Munks, R.J., Kaptein, A., Farrow, S., Howells, L., Inhibition of cyclo-oxygenase 2 expression in colon cells by the chemopreventive agent curcumin involves inhibition of NF-kappaB activation via the NIK/IKK signalling complex. Oncogene 18:44 (1999), 6013–6020.
33. Mancuso, C., Barone, E., Curcumin in clinical practice: myth or reality?. Trends Pharmacol. Sci. 30:7 (2009), 333–334.
34. Burgos-Moron, E., Calderon-Montano, J.M., Salvador, J., Robles, A., Lopez-Lazaro, M., The dark side of curcumin. Int. J. Cancer 126:7 (2010), 1771–1775.
35. Nelson, K.M., Dahlin, J.L., Bisson, J., Graham, J., Pauli, G.F., Walters, M.A., The essential medicinal chemistry of curcumin. J. Med. Chem. 60:5 (2017), 1620–1637.
36. Huminiecki, L., Lloyd, A.T., Wolfe, K.H., Congruence of tissue expression profiles from Gene Expression Atlas, SAGEmap and TissueInfo databases. BMC Genom., 4(1), 2003, 31.
37. Kuo, W.P., Jenssen, T.K., Butte, A.J., Ohno-Machado, L., Kohane, I.S., Analysis of matched mRNA measurements from two different microarray technologies. Bioinformatics 18:3 (2002), 405–412.
38. Van Erk, M.J., Teuling, E., Staal, Y.C., Huybers, S., Van Bladeren, P.J., Aarts, J.M., Van Ommen, B., Time- and dose-dependent effects of curcumin on gene expression in human colon cancer cells. J. Carcinog., 3(1), 2004, 8.
39. Chen, H.W., Yu, S.L., Chen, J.J., Li, H.N., Lin, Y.C., Yao, P.L., Chou, H.Y., Chien, C.T., Chen, W.J., Lee, Y.T., Yang, P.C., Anti-invasive gene expression profile of curcumin in lung adenocarcinoma based on a high throughput microarray analysis. Mol. Pharmacol. 65:1 (2004), 99–110.
40. Ramachandran, C., Rodriguez, S., Ramachandran, R., Raveendran Nair, P.K., Fonseca, H., Khatib, Z., Escalon, E., Melnick, S.J., Expression profiles of apoptotic genes induced by curcumin in human breast cancer and mammary epithelial cell lines. Anticancer Res. 25:5 (2005), 3293–3302.
41. Mariadason, J.M., Corner, G.A., Augenlicht, L.H., Genetic reprogramming in pathways of colonic cell maturation induced by short chain fatty acids: comparison with trichostatin A, sulindac, and curcumin and implications for chemoprevention of colon cancer. Cancer Res. 60:16 (2000), 4561–4572.
42. Teiten, M.H., Eifes, S., Reuter, S., Duvoix, A., Dicato, M., Diederich, M., Gene expression profiling related to anti-inflammatory properties of curcumin in K562 leukemia cells. Ann. N. Y. Acad. Sci. 1171 (2009), 391–398.
43. Marquardt, J.U., Gomez-Quiroz, L., Arreguin Camacho, L.O., Pinna, F., Lee, Y.H., Kitade, M., Dominguez, M.P., Castven, D., Breuhahn, K., Conner, E.A., Galle, P.R., Andersen, J.B., Factor, V.M., Thorgeirsson, S.S., Curcumin effectively inhibits oncogenic NF-kappaB signaling and restrains stemness features in liver cancer. J. Hepatol. 63:3 (2015), 661–669.
44. Chiang, I.T., Wang, W.S., Liu, H.C., Yang, S.T., Tang, N.Y., Chung, J.G., Curcumin alters gene expression-associated DNA damage, cell cycle, cell survival and cell migration and invasion in NCI-H460 human lung cancer cells in vitro. Oncol. Rep. 34:4 (2015), 1853–1874.
45. Krek, A., Grun, D., Poy, M.N., Wolf, R., Rosenberg, L., Epstein, E.J., MacMenamin, P., da Piedade, I., Gunsalus, K.C., Stoffel, M., Rajewsky, N., Combinatorial microRNA target predictions. Nat. Genet. 37:5 (2005), 495–500.
46. Agarwal, V., Bell, G.W., Nam, J.W., Bartel, D.P., Predicting effective microRNA target sites in mammalian mRNAs. Elife, 4, 2015.
47. Griffiths-Jones, S., Saini, H.K., van Dongen, S., Enright, A.J., miRBase: tools for microRNA genomics. Nucleic Acids Res. 36:Database issue (2008), D154–8.
48. Griffiths-Jones, S., Grocock, R.J., van Dongen, S., Bateman, A., Enright, A.J., miRBase: microRNA sequences, targets and gene nomenclature. Nucleic Acids Res. 34:Database issue (2006), D140–D144.
49. Wong, N., Wang, X., miRDB: an online resource for microRNA target prediction and functional annotations. Nucleic Acids Res. 43:Database issue (2015), D146–52.
50. Wang, X., Improving microRNA target prediction by modeling with unambiguously identified microRNA-target pairs from CLIP-ligation studies. Bioinformatics 32:9 (2016), 1316–1322.
51. Sun, M., Estrov, Z., Ji, Y., Coombes, K.R., Harris, D.H., Kurzrock, R., Curcumin (diferuloylmethane) alters the expression profiles of microRNAs in human pancreatic cancer cells. Mol. Cancer Ther. 7:3 (2008), 464–473.
52. Huang da, W., Sherman, B.T., Lempicki, R.A., Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat. Protoc. 4:1 (2009), 44–57.
53. Xu, D., Takeshita, F., Hino, Y., Fukunaga, S., Kudo, Y., Tamaki, A., Matsunaga, J., Takahashi, R.U., Takata, T., Shimamoto, A., Ochiya, T., Tahara, H., miR-22 represses cancer progression by inducing cellular senescence. J. Cell Biol. 193:2 (2011), 409–424.
54. Zuo, Q.F., Cao, L.Y., Yu, T., Gong, L., Wang, L.N., Zhao, Y.L., Xiao, B., Zou, Q.M., MicroRNA-22 inhibits tumor growth and metastasis in gastric cancer by directly targeting MMP14 and Snail. Cell. Death. Dis., 6, 2015, e2000.
55. Xiong, J., Du, Q., Liang, Z., Tumor-suppressive microRNA-22 inhibits the transcription of E-box-containing c-Myc target genes by silencing c-Myc binding protein. Oncogene 29:35 (2010), 4980–4988.
56. Zhang, J., Yang, Y., Yang, T., Liu, Y., Li, A., Fu, S., Wu, M., Pan, Z., Zhou, W., microRNA-22, downregulated in hepatocellular carcinoma and correlated with prognosis, suppresses cell proliferation and tumourigenicity. Br. J. Cancer 103:8 (2010), 1215–1220.
57. Ye, M., Zhang, J., Miao, Q., Yao, L., Curcumin promotes apoptosis by activating the p53-miR-192-5p/215-XIAP pathway in non-small cell lung cancer. Cancer Lett. 357:1 (2015), 196–205.
58. Zhou, Q.M., Chen, Q.L., Du, J., Wang, X.F., Lu, Y.Y., Zhang, H., Su, S.B., Synergistic effect of combinatorial treatment with curcumin and mitomycin C on the induction of apoptosis of breast cancer cells: a cDNA microarray analysis. Int. J. Mol. Sci. 15:9 (2014), 16284–16301.
59. Dahmke, I.N., Backes, C., Rudzitis-Auth, J., Laschke, M.W., Leidinger, P., Menger, M.D., Meese, E., Mahlknecht, U., Curcumin intake affects miRNA signature in murine melanoma with mmu-miR-205-5p most significantly altered. PLoS One, 8(12), 2013, e81122.
60. Graf, L.H., Kaplan, P. Jr., Silagi, S., Efficient DNA-mediated transfer of selectable genes and unselected sequences into differentiated and undifferentiated mouse melanoma clones. Somat. Cell Mol. Genet. 10:2 (1984), 139–151.
61. Bisht, S., Maitra, A., Systemic delivery of curcumin: 21st century solutions for an ancient conundrum. Curr. Drug Discov. Technol. 6:3 (2009), 192–199.
62. Link, A., Balaguer, F., Shen, Y., Lozano, J.J., Leung, H.C., Boland, C.R., Goel, A., Curcumin modulates DNA methylation in colorectal cancer cells. PLoS One, 8(2), 2013, e57709.
63. Colacino, J.A., McDermott, S.P., Sartor, M.A., Wicha, M.S., Rozek, L.S., Transcriptomic profiling of curcumin-treated human breast stem cells identifies a role for stearoyl-coa desaturase in breast cancer prevention. Breast Cancer Res. Treat. 158:1 (2016), 29–41.
64. Zhao, W., Wang, Y., Gao, N., Han, Z., Yu, H., Potential anti-cancer effect of curcumin in human lung squamous cell carcinoma. Thorac. Cancer 6:4 (2015), 508–516.
65. Al-Hajj, M., Wicha, M.S., Benito-Hernandez, A., Morrison, S.J., Clarke, M.F., Prospective identification of tumorigenic breast cancer cells. Proc. Natl. Acad. Sci. U. S. A. 100:7 (2003), 3983–3988.
66. Cine, N., Limtrakul, P., Sunnetci, D., Nagy, B., Savli, H., Effects of curcumin on global gene expression profiles in the highly invasive human breast carcinoma cell line MDA-MB 231: A gene network-based microarray analysis. Exp. Ther. Med. 5:1 (2013), 23–27.
67. Zhang, J., Du, Y., Wu, C., Ren, X., Ti, X., Shi, J., Zhao, F., Yin, H., Curcumin promotes apoptosis in human lung adenocarcinoma cells through miR-186* signaling pathway. Oncol. Rep. 24:5 (2010), 1217–1223.
68. Rao, C.V., Kawamori, T., Hamid, R., Reddy, B.S., Chemoprevention of colonic aberrant crypt foci by an inducible nitric oxide synthase-selective inhibitor. Carcinogenesis 20:4 (1999), 641–644.
69. Vyas, A., Dandawate, P., Padhye, S., Ahmad, A., Sarkar, F., Perspectives on new synthetic curcumin analogs and their potential anticancer properties. Curr. Pharm. Des. 19:11 (2013), 2047–2069.
70. Kanehisa, M., Goto, S., Kawashima, S., Okuno, Y., Hattori, M., The KEGG resource for deciphering the genome. Nucleic Acids Res. 32:Database issue (2004), D277–80.
71. Ashburner, M., Ball, C.A., Blake, J.A., Botstein, D., Butler, H., Cherry, J.M., Davis, A.P., Dolinski, K., Dwight, S.S., Eppig, J.T., Harris, M.A., Hill, D.P., Issel-Tarver, L., Kasarskis, A., Lewis, S., Matese, J.C., Richardson, J.E., Ringwald, M., Rubin, G.M., Sherlock, G., Gene ontology: tool for the unification of biology. The Gene Ontology Consortium. Nat. Genet. 25:1 (2000), 25–29.
72. Subramanian, A., Tamayo, P., Mootha, V.K., Mukherjee, S., Ebert, B.L., Gillette, M.A., Paulovich, A., Pomeroy, S.L., Golub, T.R., Lander, E.S., Mesirov, J.P., Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proc. Natl. Acad. Sci. U. S. A. 102:43 (2005), 15545–15550.
73. Eisen, M.B., Spellman, P.T., Brown, P.O., Botstein, D., Cluster analysis and display of genome-wide expression patterns. Proc. Natl. Acad. Sci. U. S. A. 95:25 (1998), 14863–14868.
74. Backes, C., Keller, A., Kuentzer, J., Kneissl, B., Comtesse, N., Elnakady, Y.A., Muller, R., Meese, E., Lenhof, H.P., GeneTrail-advanced gene set enrichment analysis. Nucleic Acids Res. 35:Web Server issue (2007), W186–W192.